Over the past decades, lipid‐based nanoparticle drug delivery systems (DDS) have caught
the attention of researchers worldwide, encouraging the field to rapidly develop improved …

Nanoparticles (NPs) have attracted tremendous interest in drug delivery in the past decades.
Microfluidics offers a promising strategy for making NPs for drug delivery due to its capability …

Gold nanomaterials have attracted considerable interest as vehicles for intracellular drug
delivery. In our study, we synthesized three different shapes of methylpolyethylene glycol …

Control over vesicle size during nanoscale liposome synthesis is critical for defining the
pharmaceutical properties of liposomal nanomedicines. Microfluidic technologies capable of …

Microfluidic devices present unique advantages for the development of efficient drug carrier
particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening …

Background The application of liposomal system in food area allowing carried and
controlled bioactive-molecules release has been considered one of the main strategies …

This paper provides an analysis of microfluidic techniques for the production of nanoscale
lipid-based vesicular systems. In particular we focus on the key issues associated with the …

Lipid nanoparticles (LNPs) are currently the most clinically advanced nonviral carriers for the
delivery of small interfering RNA (siRNA). Free siRNA molecules suffer from unfavorable …

This work is aimed at providing a description of the complex world of drug carriers, starting
from the description of this particular market in terms of revenue. Then, a brief overview of …

Lipid‐based nanoparticles have emerged as a clinically viable platform technology to
deliver nucleic acids for a wide range of healthcare applications. Within this scope, one of …